All News
Filter News
Found 808,890 articles
-
GlaxoSmithKline Presents Pipeline of 40 Drugs, 20 Up for Filing and Launch in Next 5 Years
11/4/2015
-
Roche Plans New $136 Million Innovation Center In Shanghai
11/4/2015
-
Novo Nordisk A/S Release: Data Presented At ObesityWeek Showed Saxenda (liraglutide [rDNA origin] injection) Treatment Demonstrated Significant And Sustained Weight Loss Over Three Years Compared With Placebo
11/4/2015
-
AcelRx Presents Data From Phase 3 Clinical Trials Evaluating The Safety And Efficacy Of Zalviso In Obese Surgical Patients
11/4/2015
-
scPharmaceuticals Announces Positive Results From Pivotal Trial Of Its Novel Subcutaneous Furosemide Formulation In Patients With Heart Failure
11/4/2015
-
Merck KGaA And Pfizer Announce Initiation Of Phase III First-Line Trial Of Avelumab In Patients With Recurrent Or Stage IV Non-Small Cell Lung Cancer
11/4/2015
-
How Johnson & Johnson And Celgene Are Winning In The Clinic
11/4/2015
-
Shire's New Buy Dyax is Another Biotech with Ties to Genzyme
11/4/2015
-
Nature Release: Publication In aTyr Pharma Demonstrates Physiocrine Genetic Mutation Disrupts A Key Signaling Pathway In Neuronal Biology
11/4/2015
-
Brent Saunders, in Shadow of Pfizer Acquisition, Took Allergan from $25 Billion to $120 Billion
11/4/2015
-
Adocia Announces Positive Phase 1b Results On The Post-Meal Effect Of BioChaperone Combo In Patients With Type 1 Diabetes
11/4/2015
-
ViiV Healthcare Hitting Hard But Gilead Management is Well-Prepared
11/4/2015
-
Espero Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Gonitro (Nitroglycerin Powder For Sublingual Use)
11/4/2015
-
Marina Biotech, Inc. Reports That Licensee ProNAi Therapeutics, Inc. Initiates "Brighton" Phase II Trial Of PNT2258 In Patients With Richter's Transformation
11/4/2015
-
CASI Pharmaceuticals Announces First Patient Dosed In Phase 2 Trial For ENMD-2076 In Fibrolamellar Carcinoma (FLC)
11/4/2015
-
NovaBay Completes 34 Patient Phase 2B Clinical Study
11/4/2015
-
Helix Biopharma Initiates Enrollment For Fourteenth Cohort In Polish Phase I/II Clinical Study Of Its L-DOS47 Lung Cancer Drug
11/4/2015
-
Halozyme Announces First Clinical Dosing Of Janssen Biotech Inc.'s Daratumumab Using ENHANZE Technology
11/4/2015
-
TRANSGENE Announces Dosing Of First Patient With TG1050 For Treatment Of Chronic Hepatitis B Infection
11/4/2015
-
ProMetic BioSciences, Inc.'s Plasminogen Drug Successfully Used To Treat Plasminogen Deficient Infant In Critical Condition
11/4/2015